Last update 04 Nov 2024
Borui Xinchuang Biomedical Technology (Wuxi) Co., Ltd
Private Company | Subsidiary Company|
2021|
Jiangsu Sheng, China
Last update 04 Nov 2024
Overview
Basic Info
Introduction Borui Xinchuang Biomedical Technology (Wuxi) Co., Ltd. was established on November 19, 2021, with its business scope including licensed activities such as pharmaceutical import and export, drug wholesale, and general activities like technical services, development, consulting, exchange, transfer, and promotion. |
Tags
Endocrinology and Metabolic Disease
Synthetic peptide
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
评估 BGM0504 注射液在非糖尿病的超重或肥胖受试者中多次给药的安全性、 耐受性、 PK/PD 特征和有效性的随机、 双盲、 安慰剂平行对照 II 期临床研究
[Translation] A randomized, double-blind, placebo-controlled, parallel-group Phase II clinical study to evaluate the safety, tolerability, PK/PD characteristics and efficacy of BGM0504 injection after multiple doses in non-diabetic overweight or obese subjects
评估 BGM0504 注射液在 2 型糖尿病患者中多次给药的安全性、 耐受性、 药代动力学和药效学特征的随机、 双盲、 安慰剂及阳性药平行对照 IIa 期临床研究
[Translation] A randomized, double-blind, placebo- and active drug-controlled Phase IIa clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BGM0504 injection after repeated administration in patients with type 2 diabetes
评价健康志愿者中 BGM0504 注射液单次给药和每周给药一次连续给药二周、渐进到目标剂量的安全性、 耐受性、 药代动力学及药效学的随机、 双盲、 安慰剂对照、 剂量递增 Ia 期临床研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalation Phase Ia clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGM0504 injection in healthy volunteers after single administration and weekly administration for two weeks, gradually increasing to the target dose
100 Clinical Results associated with Borui Xinchuang Biomedical Technology (Wuxi) Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Borui Xinchuang Biomedical Technology (Wuxi) Co., Ltd
Login to view more data
100 Translational Medicine associated with Borui Xinchuang Biomedical Technology (Wuxi) Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 26 Dec 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free